RespireRx Pharmaceuticals Inc (fka RSPI)

[gershfinance]

We're now back at pre-announcement levels. I'm not a chartist, but it seems we have now "filled the gap" from the original dosing-lifted news. Its a bad market, no buyers, and significant sellers from a) warrants, b) people who bought for the pop that never really materialized or during the pop that are now 15% underwater, c) frustrated longs tired of waiting., and d) folks GFP has managed to scare with his dead-horse beating questions. I'm WAY overweighted in COR, but the risk-reward profile has really never looked better. I'm a buyer of more today at 2.76, and hoping the second half of the year will bring more news under better market conditions to see some of the promise of this "little gem" fulfilled.